MDxHealth Announces Agreement with SouthGenetics for Distribution of SelectMDx in Central/South America
October 04, 2016 01:04 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, Oct. 4, 2016 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext: MDXH.BR) a multinational healthcare company that provides actionable epigenetic information to personalize...
MDxHealth (R): Grants QIAGEN Rights to MSP Technology for QIAsure Methylation Test for Cervical Cancer Risk
June 15, 2016 01:07 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, June 15, 2016 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext: MDXH.BR), announced today that it has granted a non-exclusive worldwide license for its patented...
MDxHealth(R): Completion of the acquisition of NovioGendix - New share capital amount and new number of shares
September 18, 2015 11:32 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, Sept. 18, 2015 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext Brussels: MDXH) (the "Company") announced today that it succesfully completed the acquisition of all of...
MDxHealth's ConfirmMDx(r) Predicts Prostate Cancer Aggressiveness
May 18, 2015 02:04 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, May 18, 2015 (GLOBE NEWSWIRE) -- Epigenetic Health Index Helps Urologists with Prognostic Recommendations...
MDxHealth (R) : MDxHealth Licensee Exact Sciences Receives FDA Approval for its Cologuard Colon Cancer Screening Assay
August 12, 2014 03:04 ET
|
MdxHealth (TM)
IRVINE, Calif. , and HERSTAL, Belgium, Aug. 12, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests...
ConfirmMDx Studies Highlighted by Elsevier, Publisher of The Journal of Urology(r)
July 22, 2014 02:08 ET
|
MdxHealth (TM)
LIEGE, Belgium, July 22, 2014 (GLOBE NEWSWIRE) -- Underscores Importance of Recent Confirmatory Clinical Validation Results Leading to Medicare Reimbursement...
MDxHealth Signs Agreement with Galaxy Health Network PPO Providing Increased Access to ConfirmMDx for Prostate Cancer
April 22, 2014 02:08 ET
|
MdxHealth (TM)
Agreement Increases Access with Additional 3.5 Million Covered Lives
IRVINE, Calif. and HERSTAL, Belgium, April 22, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular...
MDxHealth and LI PATH Announce Marketing Agreement for ConfirmMDx for Prostate Cancer
April 02, 2014 02:10 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, April 2, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...
MDxHealth Reports Fourth Quarter and Fiscal Year 2013 Results
February 27, 2014 02:04 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, Feb. 27, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...
MDxHealth's ConfirmMDx(R) for Prostate Cancer Epigenetic Test Correctly Identifies Prostate Cancer Missed in Five Previous Biopsies
February 12, 2014 02:09 ET
|
MdxHealth (TM)
IRVINE, Calif. and HERSTAL, Belgium, Feb. 12, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to...